| Radiopharmaceutical therapy in cancer: clinical advances and challenges G Sgouros, L Bodei, MR McDevitt, JR Nedrow Nature reviews Drug discovery 19 (9), 589-608, 2020 | 513 | 2020 |
| Imaging, biodistribution, and dosimetry of radionuclide-labeled PD-L1 antibody in an immunocompetent mouse model of breast cancer A Josefsson, JR Nedrow, S Park, SR Banerjee, A Rittenbach, F Jammes, ... Cancer research 76 (2), 472-479, 2016 | 168 | 2016 |
| Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen–targeted imaging agent for prostate cancer SE Lapi, H Wahnishe, D Pham, LY Wu, JR Nedrow-Byers, T Liu, ... Journal of Nuclear Medicine 50 (12), 2042-2048, 2009 | 122 | 2009 |
| Imaging of programmed cell death ligand 1: impact of protein concentration on distribution of anti-PD-L1 SPECT agents in an immunocompetent murine model of melanoma JR Nedrow, A Josefsson, S Park, S Ranka, S Roy, G Sgouros Journal of Nuclear Medicine 58 (10), 1560-1566, 2017 | 82 | 2017 |
| Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles BB Kasten, T Liu, JR Nedrow-Byers, PD Benny, CE Berkman Bioorganic & medicinal chemistry letters 23 (2), 565-568, 2013 | 72 | 2013 |
| A phosphoramidate‐based prostate‐specific membrane antigen‐targeted SPECT agent JR Nedrow‐Byers, M Jabbes, C Jewett, T Ganguly, H He, T Liu, P Benny, ... The Prostate 72 (8), 904-912, 2012 | 69 | 2012 |
| PSMA‐targeted SPECT agents: Mode of binding effect on in vitro performance JR Nedrow‐Byers, AL Moore, T Ganguly, MR Hopkins, MD Fulton, ... The Prostate 73 (4), 355-362, 2013 | 48 | 2013 |
| Evaluation of 68Ga- and 177Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma W Beaino, JR Nedrow, CJ Anderson Molecular pharmaceutics 12 (6), 1929-1938, 2015 | 47 | 2015 |
| Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate T Liu, JR Nedrow-Byers, MR Hopkins, LY Wu, J Lee, PTA Reilly, ... Bioorganic & medicinal chemistry letters 22 (12), 3931-3934, 2012 | 46 | 2012 |
| Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium T Liu, M Jabbes, JR Nedrow-Byers, LY Wu, JN Bryan, CE Berkman International journal of oncology 38 (5), 1349-1355, 2011 | 45 | 2011 |
| Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model JR Nedrow, A Josefsson, S Park, T Bäck, RF Hobbs, C Brayton, ... EJNMMI research 7, 1-16, 2017 | 43 | 2017 |
| Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen T Liu, JR Nedrow-Byers, MR Hopkins, CE Berkman Bioorganic & medicinal chemistry letters 21 (23), 7013-7016, 2011 | 38 | 2011 |
| Targeting PSMA with a Cu-64 labeled phosphoramidate inhibitor for PET/CT imaging of variant PSMA-expressing xenografts in mouse models of prostate cancer JR Nedrow, JD Latoche, KE Day, J Modi, T Ganguly, D Zeng, BF Kurland, ... Molecular imaging and biology 18, 402-410, 2016 | 34 | 2016 |
| Positron Emission Tomographic Imaging of Copper 64– and Gallium 68–Labeled Chelator Conjugates of the Somatostatin Agonist Tyr3-Octreotate JR Nedrow, AG White, J Modi, K Nguyen, AJ Chang, CJ Anderson Molecular imaging 13 (7), 7290.2014. 00020, 2014 | 32 | 2014 |
| Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities Z Novakova, J Cerny, CJ Choy, JR Nedrow, JK Choi, J Lubkowski, ... The FEBS journal 283 (1), 130-143, 2016 | 29 | 2016 |
| Evaluation of [225Ac] Ac-DOTA-anti-VLA-4 for targeted alpha therapy of metastatic melanoma A Cortez, A Josefsson, G McCarty, AE Shtekler, A Rao, Z Austin, ... Nuclear Medicine and Biology 88, 62-72, 2020 | 16 | 2020 |
| Human HER2 overexpressing mouse breast cancer cell lines derived from MMTV. f. HuHER2 mice: characterization and use in a model of metastatic breast cancer S Park, JR Nedrow, A Josefsson, G Sgouros Oncotarget 8 (40), 68071, 2017 | 13 | 2017 |
| The question-driven laboratory exercise: a new pedagogy applied to a green modification of Grignard reagent formation and reaction JM Teixeira, JN Byers, M Pérez García, RW Holman, MM Kirchhoff Journal of chemical education 87 (7), 714-716, 2010 | 13 | 2010 |
| Molecular imaging of chemokine-like receptor 1 (CMKLR1) in experimental acute lung injury PZ Mannes, CE Barnes, J Biermann, JD Latoche, KE Day, Q Zhu, ... Proceedings of the National Academy of Sciences 120 (3), e2216458120, 2023 | 9 | 2023 |
| Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma J Choi, A Pant, R Medikonda, YH Kim, D Routkevitch, L Saleh, L Tong, ... OncoImmunology 10 (1), 1940673, 2021 | 8 | 2021 |
